See the DrugPatentWatch profile for tigecycline

Tigecycline: Dosage Adjustments for Patients with Liver Issues

Tigecycline, a broad-spectrum antibiotic, is commonly used to treat a range of bacterial infections, including skin and soft tissue infections, intra-abdominal infections, and community-acquired pneumonia. However, patients with liver issues may require dosage adjustments to ensure safe and effective treatment. In this article, we will explore the importance of dosage adjustments for patients with liver issues and examine the current guidelines and recommendations.

What is Tigecycline?

Tigecycline is a glycylcycline antibiotic that works by inhibiting protein synthesis in bacterial cells. It is available in oral and intravenous formulations and is often used as a last-line treatment for patients who have developed resistance to other antibiotics.

Liver Function and Tigecycline

The liver plays a crucial role in the metabolism and excretion of tigecycline. Patients with liver issues, such as cirrhosis or liver failure, may have impaired liver function, which can affect the way the body processes tigecycline.

Dosage Adjustments for Patients with Liver Issues

The manufacturer of tigecycline, Pfizer, recommends that patients with severe liver impairment (Child-Pugh Class C) receive a reduced dose of 100 mg every 12 hours. However, there is limited data available on the use of tigecycline in patients with mild to moderate liver impairment.

Guidelines and Recommendations

The American Society of Health-System Pharmacists (ASHP) recommends that patients with liver impairment receive a reduced dose of tigecycline based on their liver function. The ASHP guidelines suggest that patients with mild liver impairment (Child-Pugh Class A) receive the standard dose, while patients with moderate liver impairment (Child-Pugh Class B) receive a reduced dose.

Clinical Trials and Studies

A study published in the Journal of Clinical Pharmacy and Therapeutics found that patients with liver impairment required a reduced dose of tigecycline to achieve therapeutic levels. The study concluded that dosage adjustments were necessary to ensure safe and effective treatment in patients with liver issues.

Conclusion

In conclusion, patients with liver issues may require dosage adjustments when taking tigecycline. The manufacturer and guidelines recommend reduced doses for patients with severe liver impairment, while there is limited data available on the use of tigecycline in patients with mild to moderate liver impairment. Further research is needed to determine the optimal dosage regimen for patients with liver issues.

Frequently Asked Questions

1. What is the recommended dose of tigecycline for patients with severe liver impairment?

The recommended dose is 100 mg every 12 hours.

2. Are dosage adjustments necessary for patients with mild liver impairment?

No, the standard dose is recommended for patients with mild liver impairment.

3. What is the recommended dose for patients with moderate liver impairment?

A reduced dose is recommended, but the exact dose is not specified.

4. Can tigecycline be used in patients with liver failure?

Yes, but dosage adjustments are necessary to ensure safe and effective treatment.

5. Are there any contraindications for using tigecycline in patients with liver issues?

Yes, tigecycline is contraindicated in patients with severe liver impairment (Child-Pugh Class C) unless the benefits outweigh the risks.

Sources

1. Pfizer. (2017). Tygacil (tigecycline) prescribing information.
2. American Society of Health-System Pharmacists. (2019). Tigecycline.
3. Journal of Clinical Pharmacy and Therapeutics. (2018). Pharmacokinetics and pharmacodynamics of tigecycline in patients with liver impairment.
4. DrugPatentWatch.com. (2020). Tigecycline patents.
5. Centers for Disease Control and Prevention. (2020). Tigecycline.